Isabelle Côté is the Vice President, Head of Global Market Access and Innovation at Genmab, with extensive experience in health economics and market access from previous roles at Bayer, Hoffmann-La Roche, Pfizer Pharmaceuticals, and other leading companies. They have led various submissions, including those for Avastin® and Revatio®, and have built and mentored market access teams across multiple therapeutic areas. Isabelle holds a PhD in Pharmacoepidemiology from Université Laval and has a solid academic background in economics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices